CD44 and posterior cortical atrophy: In 2005, with the successful isolation of CD44+/α2β1hi/CD133+ enriched cells from a human prostate tumor, Collins et al. found that this small population of PCa cells possessed self-renewal ability and were enabled to differentiate into non-clonal tumor cells [33].